New R&D models needed to tackle drug-resistant TB

Why has research and development failed to deliver desperately needed tuberculosis treatments for so long, and what can be done about it? Global health experts weigh in.

About the author

  • Gabriella Jóźwiak

    Gabriella Jóźwiak is an award-winning journalist based in London. Her work on issues and policies affecting children and young people in developing countries and the U.K. has been published in national newspapers and magazines. Having worked in-house for domestic and international development charities, Jóźwiak has a keen interest in organizational development, and has worked as a journalist in several countries across West Africa and South America.